Text-only version of this email
LIXTE Biotechnology Holdings, Inc.
The following documents have been filed with the SEC:
SEC FILING ALERT
8-K: Current report filing
HTML PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
LIXTE Biotechnology Holdings, Inc.
680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America
To change your subscription preferences, please click here.
Show all